药品专利强制许可制度对提高我国药品可获得性的可能性及相关对策探讨  

Possibility of Increased Access to Medicine under Medicine Patents Compulsory License System and Discussion on Correlative Countermeasures

作　　者：汤晶晶[1] 邵蓉[1] 

机构地区：[1]中国药科大学国际医药商学院,南京市210009

出　　处：《中国药房》2006年第6期407-409,共3页China Pharmacy

摘　　要：目的:为在公共健康危机发生时,能有效降低专利药品价格,提高药品的可获得性。方法:结合我国实际情况,分析药品专利强制许可措施不适用的原因。结果与结论:政府应寻求其他有效途径,增加药品的可获得性,改善宏观政策环境,并鼓励企业增强自身实力。OBJECTIVE： To lower the price of patent medicine effectively and to increase the access to medicine when public health crises occur. METHODS： Based on the real situation in China, reasons for the inapplicability of compulsory license system for medicine patents were analyzed. RESULTS ＆ CONCLUSION： Chinese government should avoid bulwark of patent and try to explore effective ways to improve the macroscopic policy environment and encourage enterprises to boost up their own strength.

关 键 词：药品专利强制许可 公共健康危机 药品可获得性 对策 

分 类 号：R95[医药卫生—药学]